<?xml version="1.0" encoding="UTF-8"?>
<ref id="B102-microorganisms-08-01228">
 <label>102.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Zhang</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Shen</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Qi</surname>
    <given-names>Z.</given-names>
   </name>
  </person-group>
  <article-title>Rational use of Tocilizumab in the treatment of novel coronavirus pneumonia</article-title>
  <source>Clin. Drug Investig.</source>
  <year>2020</year>
  <volume>40</volume>
  <fpage>511</fpage>
  <lpage>518</lpage>
  <pub-id pub-id-type="doi">10.1007/s40261-020-00917-3</pub-id>
 </element-citation>
</ref>
